Skip to Main Content

Author Details

Umesh Bhanot
Memorial Sloan Kettering Cancer Center
2001
49
24
PMIDPaper TitleJournal TitlePublished Year
36711976Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.bioRxiv2023
37406106Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.Clin Cancer Res2023
36711976Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.bioRxiv2023
36821179Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities.Arch Pathol Lab Med2023
37001526Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade.Cancer Cell2023
37182602Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification.J Thorac Oncol2023
37531417Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.Sci Transl Med2023
37531417Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.Sci Transl Med2023
37182602Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification.J Thorac Oncol2023
37406106Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.Clin Cancer Res2023
37001526Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade.Cancer Cell2023
36821179Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities.Arch Pathol Lab Med2023
34815254Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy.Cancer Res2022
35585047Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.Nat Commun2022
35440124Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts.Nat Commun2022
34815254Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy.Cancer Res2022
35585047Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.Nat Commun2022
35440124Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts.Nat Commun2022
34260720Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.J Am Med Inform Assoc2021
34260720Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.J Am Med Inform Assoc2021
33756102Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer.Immunity2021
34656143Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation.J Hematol Oncol2021
34653364Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.Cancer Cell2021
33756102Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer.Immunity2021
34656143Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation.J Hematol Oncol2021
34653364Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.Cancer Cell2021
33264619Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer.Cell Rep2020
32076273ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.Nature2020
33264619Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer.Cell Rep2020
32076273ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.Nature2020
29760048Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers.Cancer Res2018
30138725Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer.J Mol Diagn2018
29760048Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers.Cancer Res2018
30138725Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer.J Mol Diagn2018
27751729Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.Eur Urol2017
28776573Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Mod Pathol2017
29535801Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Oncotarget2017
29132146Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.Nature2017
27751729Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.Eur Urol2017
29535801Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Oncotarget2017
29132146Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.Nature2017
28776573Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Mod Pathol2017
27282351The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.Mod Pathol2016
27282351The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.Mod Pathol2016
25605237The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.Oncotarget2015
25840541GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.J Am Coll Surg2015
25605237The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.Oncotarget2015
26489647Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.Proc Natl Acad Sci U S A2015
26489647Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.Proc Natl Acad Sci U S A2015
25840541GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.J Am Coll Surg2015
  • 1 - 50 of 98

Recommended Authors

Ashton A Connor
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 0
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Career Start Year 2009
Number of shared co-authors 1
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 1
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 3
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 1
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 2
Sharad C Mathur
Kansas City VA Medical Center
Career Start Year 1998
Number of shared co-authors 0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 1
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 8
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
Nabeel Bardeesy
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 3
Kerrington D Smith
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 0
Nathan Bahary
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 1
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 3
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 4
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 10
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Andrew M Lowy
University of California San Diego
Career Start Year 1985
Number of shared co-authors 0
Richard D Schulick
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 4
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 0
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 14

Collaborators

Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Elisa de Stanchina
Co-authored papers 8
Michael F Berger
Co-authored papers 5
Andrew Chow
Co-authored papers 5
John T Poirier
Laura and Isaac Perlmutter Cancer Center
Co-authored papers 4
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Nicholas D Socci
Co-authored papers 3
Richard Koche
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 2
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Mithat Gonen
Co-authored papers 2
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Dominik Glodzik
Co-authored papers 2
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Nicolas Robine
Sloan-Kettering Institute
Co-authored papers 2
Brad R Rosenberg
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Elliott H Margulies
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 2
Xiaomu Wei
Cornell University
Co-authored papers 2
Stephen C J Parker
University of Michigan ann arbor
Co-authored papers 2
Anne-Katrin Emde
Variant Bio Inc.
Co-authored papers 2
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Steven E Robinson
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 1
Arnold J Levine
Simons Center for Systems Biology, Institute for Advanced Study
Co-authored papers 1
Benjamin D Greenbaum
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Ronglai Shen
Co-authored papers 1
Matthias A Karajannis
Co-authored papers 1
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 1
Release 1.2